tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RXRX Stock Latest News

Recursion Pharmaceuticals put volume heavy and directionally bearish
The FlyRecursion Pharmaceuticals put volume heavy and directionally bearish
7d ago
RXRX
Recursion Pharmaceuticals price target lowered to $12 from $16 at KeyBanc
PremiumThe Fly
Recursion Pharmaceuticals price target lowered to $12 from $16 at KeyBanc
14d ago
RXRX
Cathie Wood’s ARK Investment bought 143K shares of Recursion Pharmaceuticals
PremiumThe Fly
Cathie Wood’s ARK Investment bought 143K shares of Recursion Pharmaceuticals
16d ago
RXRX
Cathie Wood’s ARK Investment bought 423K shares of Recursion Pharmaceuticals
PremiumThe Fly
Cathie Wood’s ARK Investment bought 423K shares of Recursion Pharmaceuticals
17d ago
RXRX
AI Could Revolutionize Drug Discovery: A Look at Key Players 
PremiumMarket News
AI Could Revolutionize Drug Discovery: A Look at Key Players 
17d ago
GS
TAK
Cathie Wood’s ARK Investment bought 505K shares of Recursion Pharmaceuticals
PremiumThe FlyCathie Wood’s ARK Investment bought 505K shares of Recursion Pharmaceuticals
23d ago
RXRX
Cathie Wood’s ARK Investment bought 204K shares of Recursion Pharmaceuticals
PremiumThe Fly
Cathie Wood’s ARK Investment bought 204K shares of Recursion Pharmaceuticals
24d ago
RXRX
Cathie Wood’s ARK Investment bought 2.9M shares of Recursion Pharmaceuticals
PremiumThe Fly
Cathie Wood’s ARK Investment bought 2.9M shares of Recursion Pharmaceuticals
28d ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
28d ago
RXRX
Recursion Pharmaceuticals 30.8M share Spot Secondary priced at $6.50
PremiumThe Fly
Recursion Pharmaceuticals 30.8M share Spot Secondary priced at $6.50
29d ago
RXRX
Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
PremiumPress Releases
Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
29d ago
RXRX
Recursion Pharmaceuticals $200M Spot Secondary; price range $7.50-$8.00
PremiumThe Fly
Recursion Pharmaceuticals $200M Spot Secondary; price range $7.50-$8.00
29d ago
RXRX
Recursion Announces Proposed Offering of Class A Common Stock
PremiumPress ReleasesRecursion Announces Proposed Offering of Class A Common Stock
29d ago
RXRX
Recursion Pharmaceuticals announces $200M Class A common stock offering
PremiumThe Fly
Recursion Pharmaceuticals announces $200M Class A common stock offering
29d ago
RXRX
Recursion Pharmaceuticals Reveals Strategy at Download Day
PremiumCompany Announcements
Recursion Pharmaceuticals Reveals Strategy at Download Day
1M ago
8K
RXRX
Recursion Pharmaceuticals gives guidance on seven clinical readouts
PremiumThe Fly
Recursion Pharmaceuticals gives guidance on seven clinical readouts
1M ago
RXRX
Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day
PremiumPress Releases
Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day
1M ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
1M ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX
Recursion to Participate in Upcoming Investor Conferences
PremiumPress ReleasesRecursion to Participate in Upcoming Investor Conferences
2M ago
RXRX
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
PremiumPress Releases
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
2M ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >